Cargando…
On model-based time trend adjustments in platform trials with non-concurrent controls
BACKGROUND: Platform trials can evaluate the efficacy of several experimental treatments compared to a control. The number of experimental treatments is not fixed, as arms may be added or removed as the trial progresses. Platform trials are more efficient than independent parallel group trials becau...
Autores principales: | Roig, Marta Bofill, Krotka, Pavla, Burman, Carl-Fredrik, Glimm, Ekkehard, Gold, Stefan M., Hees, Katharina, Jacko, Peter, Koenig, Franz, Magirr, Dominic, Mesenbrink, Peter, Viele, Kert, Posch, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380382/ https://www.ncbi.nlm.nih.gov/pubmed/35971069 http://dx.doi.org/10.1186/s12874-022-01683-w |
Ejemplares similares
-
On the use of non-concurrent controls in platform trials: a scoping review
por: Bofill Roig, Marta, et al.
Publicado: (2023) -
Commentary: Two approaches to analyze platform trials incorporating non-concurrent controls with a common assumption
por: Bofill Roig, Marta, et al.
Publicado: (2022) -
Decision rules for identifying combination therapies in open‐entry, randomized controlled platform trials
por: Meyer, Elias Laurin, et al.
Publicado: (2022) -
Sample Size Reassessment and Hypothesis Testing in Adaptive Survival Trials
por: Magirr, Dominic, et al.
Publicado: (2016) -
Designing an exploratory phase 2b platform trial in NASH with correlated, co-primary binary endpoints
por: Meyer, Elias Laurin, et al.
Publicado: (2023)